Username:
Password:
Forgot Password?
Remember me
Decade: 2000-2009
Year: 2009 2008 2007 2006 2005 Full-Text and Abstracts
Issues: Vol. 9 December, 2009 p.S374-S405-Supplement 4 Vol. 9 September, 2009 p.S179-S363-Supplement 3 Vol. 9 No. 3 June, 2009 p.E1-E13 Vol. 9 No. 2 April, 2009 p.121-182 Vol. 9 No. 1 March, 2009 p.10-112 Vol. 9 February, 2009 p.S6-S56-Supplement 2 Vol. 9 February, 2009 p.S2-S168-Supplement 1
Search Within This Issue
6 Articles:
Abstract: Chronic myeloid leukemia (CML) is a clonal stem cell disorder that is characterized by the acquired chromosomal translocation BCR-ABL. This gives rise to a constitutively active tyrosine kin...
Abstract: The successful introduction of the tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of patients with chronic myeloid leukemia (CML). Imatinib therapy induces high rates of ...
Abstract: The molecular monitoring of chronic myeloid leukemia allows the clinician a minimally invasive method to judge response to tyrosine kinase therapy and to predict outcome and relapse. Because...
Abstract: Therapy with the tyrosine kinase inhibitor (TKI) represents the current standard first-line therapy for the management of patients with chronic myeloid leukemia (CML). Although most patients...